We can't find the internet
Attempting to reconnect
14576.1;7 PFLS-LS
Oral biomarkers for early diagnosis of fibrotic inflammatory bowel disease (IBD)
Zusammenfassung
Oral biomarkers for early diagnosis of fibrotic inflammatory bowel disease (IBD)
Weitere Texte
Abstract
We aim at developing a new oral contrast agent for the early diagnosis of fibrotic IBD by means of confocal endomicroscopy. Our imaging agent will be not absorbable, resist digestion in the gut, bind with high specificity to the disease site, and be easily manufactured. Such a tailored IBD probe will be more patient-friendly, making the endoscopic examination less labour intensive, and it would open new horizons in terms of diagnosis and timely treatments.
Beteiligte
Jean-Christophe Leroux
Kontaktperson
jean-christophe.leroux@pharma.ethz.ch
ETH Zürich Jean-Christophe Leroux Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2012-10-31
- Enddatum
- 2014-10-22
- Bewilligte Gesamtkosten
- CHF 294076.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%